Clinical trial
A Phase II Clinical Study of KDT-3594 in Japanese Patients With Early Parkinson's Disease
NCT04867551 is registered in ClinicalTrials.gov with Kissei Pharmaceutical Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase II Clinical Study of KDT-3594 in Japanese Patients With Early Parkinson's Disease
- Lead sponsor
- Kissei Pharmaceutical Co., Ltd.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- May 15, 2021
- Completion date
- September 6, 2021
- Enrollment
- 7 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.